Paper3431817
Contrast sensitivity in multiple sclerosis. A study in 35 patients with and without optic neuritis.
Nordmann JP and 2 others. Ophthalmologica, 1987. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Contrast sensitivity in multiple sclerosis. A study in 35 patients with and without optic neuritis. Papers, record 3431817. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3431817
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Contrast sensitivity in multiple sclerosis. A study in 35 patients with and without optic neuritis.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Multiple Sclerosis | Major topic |
| Optic Neuritis | Major topic |
| Space Perception | Major topic |
| Adult | |
| Humans | |
| Vision Tests | |
| Visual Acuity |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41670699 | Contrast sensitivity and quality of life after orbital decompression for dysthyroid optic neuropathy. | Graefes Arch Clin Exp Ophthalmol | 2026 | https://conductscience.org/library/papers/41670699 | PubMed |
| 37875359 | Visual function changes of dysthyroid optic neuropathy and ROC curve analysis for early diagnostic indicators. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2023 | https://conductscience.org/library/papers/37875359 | PubMed |
| 33767608 | The Curve Visible on the Campbell-Robson Chart Is Not the Contrast Sensitivity Function. | Front Neurosci | 2021 | https://conductscience.org/library/papers/33767608 | PubMed |
| 32348342 | The development of the Screening of Visual Complaints questionnaire for patients with neurodegenerative disorders: Evaluation of psychometric features in a community sample. | PLoS One | 2020 | https://conductscience.org/library/papers/32348342 | PubMed |
| 24453927 | Contrast sensitivity of thyroid associated ophthalmopathy patients without obvious optic neuropathy. | ScientificWorldJournal | 2013 | https://conductscience.org/library/papers/24453927 | PubMed |
| 23459567 | Alemtuzumab improves contrast sensitivity in patients with relapsing-remitting multiple sclerosis. | Mult Scler | 2013 | https://conductscience.org/library/papers/23459567 | PubMed |
| 22737353 | Contrast Sensitivity versus Visual Evoked Potentials in Multiple Sclerosis. | J Ophthalmic Vis Res | 2010 | https://conductscience.org/library/papers/22737353 | PubMed |
| 11200548 | Measuring contrast sensitivity in patients with Graves' ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy. | Doc Ophthalmol | 2000 | https://conductscience.org/library/papers/11200548 | PubMed |
| 8280684 | Contrast sensitivity function in Graves' ophthalmopathy and dysthyroid optic neuropathy. | Br J Ophthalmol | 1993 | https://conductscience.org/library/papers/8280684 | PubMed |
| 2638240 | Visual function in multiple sclerosis. | Doc Ophthalmol | 1989 | https://conductscience.org/library/papers/2638240 | PubMed |
| 1760973 | Detection of hidden visual loss in multiple sclerosis. A comparison of pattern-reversal visual evoked potentials and contrast sensitivity. | Doc Ophthalmol | 1991 | https://conductscience.org/library/papers/1760973 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3431817
GET https://conductscience.org/api/papers/v1/3431817/authors